Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy

Diabetes Care

Volumn 32, Issue 11, 2009, Pages 2075-2080

  Nguyen, Thanh T ^a   Kawasaki, Ryo ^a   Jie, Jin Wang ^a,b   Kreis, Andreas J ^a   Shaw, Jonathan ^c   Vilser, Walthard ^d   Wong, Tien Y ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d Imedos GmbH   (Germany)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERIOLE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; FLICKER LIGHT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOTOSTIMULATION; RETINA BLOOD VESSEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; VENULE;

ADULT; AGED; ARTERIOLES; CHOLESTEROL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FLICKER FUSION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIGHT; MIDDLE AGED; REFERENCE VALUES; RETINA; RISK FACTORS; TRIGLYCERIDES; VASODILATION; VENULES;

EID: 70449360909     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0075     Document Type: Article

References (26)

1. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007;298:902-916 (Pubitemid 47311296)
2. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986 (Pubitemid 38544279)
3. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68 (Pubitemid 27261913)
4. Porta M. Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia 1996;39:739-744 (Pubitemid 26157632)
5. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008;27:161-176
6. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care 2007;30:2708-2715
7. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR,WongTY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007;30:1742-1746 (Pubitemid 47036346)
8. Matsumoto K, Sera Y, Ueki Y, Inukai G, Niiro E, Miyake S. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med 2002;19:822-826 (Pubitemid 35177180)
9. van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005;48:1300-1306 (Pubitemid 41186094)
10. Siemianowicz K, Francuz T, Gminski J, Telega A, Syzdol M. Endothelium dysfunction markers in patients with diabetic retinopathy. Int J Mol Med 2005;15:459-462
11. Spijkerman AM, Gall MA, Tarnow L, Twisk JW, Lauritzen E, Lund-Andersen H, Emeis J, Parving HH, Stehouwer CD. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes. Diabet Med 2007;24:969-976 (Pubitemid 47301646)
12. Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci 2004;45:1486-1492 (Pubitemid 38859329)
13. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 2003;285:H631-H636 (Pubitemid 36885894)
14. Mandecka A, Dawczynski J, Blum M, Muller N, Kloos C, Wolf G, Vilser W, Hoyer H, Muller UA. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007;30:3048-3052 (Pubitemid 350255244)
15. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 2004;111:1183-1190 (Pubitemid 38736998)
16. Diabetic Retinopathy Study Research Group. Design, methods, and baseline results: a modification of the Airlie House classification of diabetic retinopathy (DRS report number 7). Invest Ophthalmol Vis Sci 1981;21:1b-226b
17. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 2004;88:887-891 (Pubitemid 38869548)
18. Buerk DG, Riva CE, Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res 1996;52:13-26
19. Kondo M, Wang L, Bill A. The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand 1997;75:232-235 (Pubitemid 27315582)
20. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004;35:1289-1293 (Pubitemid 38697445)
21. Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007;26:205-238 (Pubitemid 46498800)
22. Weigert G, Pemp B, Garhofer G, Karl K, Petzl U, Wolzt M, Schmetterer L. Nitroglycerin-mediated retinal vasodilation is maintained in patients with diabetes (E-Abstract). Invest Ophthalmol Vis Sci 2008;49
23. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586:4401-4408
24. Bloomgarden ZT. Diabetic retinopathy. Diabetes Care 2008;31:1080-1083
25. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004;431:195-199
26. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007;369:425-435